Cite
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study.
MLA
Israel, Ariel, et al. “Elapsed Time since BNT162b2 Vaccine and Risk of SARS-CoV-2 Infection: Test Negative Design Study.” BMJ (Clinical Research Ed.), vol. 375, Nov. 2021, p. e067873. EBSCOhost, https://doi.org/10.1136/bmj-2021-067873.
APA
Israel, A., Merzon, E., Schäffer, A. A., Shenhar, Y., Green, I., Golan-Cohen, A., Ruppin, E., Magen, E., & Vinker, S. (2021). Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study. BMJ (Clinical Research Ed.), 375, e067873. https://doi.org/10.1136/bmj-2021-067873
Chicago
Israel, Ariel, Eugene Merzon, Alejandro A Schäffer, Yotam Shenhar, Ilan Green, Avivit Golan-Cohen, Eytan Ruppin, Eli Magen, and Shlomo Vinker. 2021. “Elapsed Time since BNT162b2 Vaccine and Risk of SARS-CoV-2 Infection: Test Negative Design Study.” BMJ (Clinical Research Ed.) 375 (November): e067873. doi:10.1136/bmj-2021-067873.